Knowledge Center

Membership Resources


Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.

After making your filter selections, please scroll down to see results.

Filters
Clear All
Results 176
Articles

Dyslipidemia & Antipsychotic Medications: Who is Monitoring the Lipids?

The use of second- generation, or atypical, antipsychotics is associated with significant adverse metabolic effects. These include weight gain, glucose intolerance, and dyslipidemia.

Read More |
Articles

Tuberous and Tendon Xanthomas: Don’t Overlook Sitosterolemia or Cerebrotendinous Xanthomatosis

Some inherited lipid disorders can be recognized by the deposition of cholesterol and other lipids in lesions on the body termed xanthomas. Lipid deposition can…

Read More |
Articles

Dyslipidemia in the Patient Living with HIV

The development and use of antiretroviral medications to treat patients infected with HIV have dramatically changed the course of this disease from one that was…

Read More |
Articles

Statins in Chronic Kidney Disease and Dialysis: Clinical Trials, Mechanisms, Dosing, and Treatment Recommendations

Patients with chronic kidney disease (CKD) including those undergoing dialysis have an increased risk of premature cardiovascular disease (CVD). CKD patients also have a high…

Read More |
Articles

Apo A1 Remnant Ratio

Although low-density lipoprotein cholesterol (LDL-C) lowering with statin therapy has been part of the National Cholesterol Education Program guidelines for 26 years, significant residual cardiovascular…

Read More |
Articles

NLA Recommendations for Patient-Centered Management of Dyslipidemia

NLA Recommendations for Patient-Centered Management of Dyslipidemia

Read More |
Articles

Firefighters and CVD: Heroes with Hearts at Risk

BackgroundThere are more than one million firefighters in the United States. Excluding the tragic loss of 342 firefighters in New York City on Sept. 11,…

Read More |
Articles

Effects of Post-Transplant Drugs on Lipids and Treatment Options

EpidemiologyThe ever- increasing population of patients living after organ transplantation has added an important dimension to the specific management needs of these patients. One major…

Read More |